Vera Therapeutics (VERA) had the highest return between January 23, 2024 and January 30, 2024 by a small-cap US stock, returning 107%.
| ASSET | DATE | % RETURN |
|---|---|---|
Vera Therapeutics (VERA) | 1/23/2024 - 1/30/2024 | 107.02% |
Clene (CLNNW) | 1/23/2024 - 1/30/2024 | 99.5% |
Arena (AREN) | 1/23/2024 - 1/30/2024 | 81.49% |
Arcutis Biotherapeutics (ARQT) | 1/23/2024 - 1/30/2024 | 63.51% |
QuantaSing Group Limited American Depositary Shares (QSG) | 1/23/2024 - 1/30/2024 | 49.44% |
Kura Oncology (KURA) | 1/23/2024 - 1/30/2024 | 46.11% |
Terawulf (WULF) | 1/23/2024 - 1/30/2024 | 37.23% |
Nukkleus (NUKKW) | 1/23/2024 - 1/30/2024 | 34.44% |
American Superconductor (AMSC) | 1/23/2024 - 1/30/2024 | 32.15% |
Compass Pathways (CMPS) | 1/23/2024 - 1/30/2024 | 30.56% |
Akso Health Group ADR (AHG) | 1/23/2024 - 1/30/2024 | 30% |
Dyne Therapeutics (DYN) | 1/23/2024 - 1/30/2024 | 28.75% |
GH Research (GHRS) | 1/23/2024 - 1/30/2024 | 27.18% |
CG Oncology, Inc Common stock (CGON) | 1/23/2024 - 1/30/2024 | 25.86% |
Liberty Oilfield Services (LBRT) | 1/23/2024 - 1/30/2024 | 23.99% |
Purecycle Technologies (PCT) | 1/23/2024 - 1/30/2024 | 23.58% |
Power Solutions International, Inc Common Stock (PSIX) | 1/23/2024 - 1/30/2024 | 23.56% |
Studio City International (MSC) | 1/23/2024 - 1/30/2024 | 22.54% |
ArriVent BioPharma, Inc Common Stock (AVBP) | 1/23/2024 - 1/30/2024 | 22.22% |
Vizsla Resources (VZLA) | 1/23/2024 - 1/30/2024 | 22.05% |
Intuitive Machines (LUNR) | 1/23/2024 - 1/30/2024 | 21.43% |
Oculis Holding AG Ordinary shares (OCS) | 1/23/2024 - 1/30/2024 | 21.25% |
Mereo BioPharma Group PLC ADR (MREO) | 1/23/2024 - 1/30/2024 | 20.19% |
Skeena Resources (SKE) | 1/23/2024 - 1/30/2024 | 20% |
Taseko Mines (TGB) | 1/23/2024 - 1/30/2024 | 20% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
